Skip to main content
. 2021 Jun 9;11:681967. doi: 10.3389/fonc.2021.681967

Table 2.

Correlation between sVEGFR1, Tumor size, CD31 and GrK.

Correlation
sVEGFR1 vs GrK
Correlation
Tumor Size vs Tumor GrK
Correlation
Tumor GrK vs CD31
control tumor mean ± SD (cm) Correlation mean ± SD (%) Correlation
r/P value r/P value Tumor size r/P value CD31+ cells# r/P value
variables (n=71) N/Percentage (%) 0.684/***<0.0001 0.452/***<0.0001 4.737 ± 1.829 -0.3593/**0.0021 5.635 ± 4.006 -0.005/0.967
Age - yr ≤60 14/19.7 0.788/**0.001 0.447/0.109 4.457 ± 1.894 -0.3705/0.191 6.182 ± 4.922 -0.2347/0.4600
>60 57/80.3 0.654/***<0.0001 0.442/**0.001 4.730 ± 1.836 -0.3778/**0.0038 6.308 ± 3.639 0.08071/0.5618
Gender Male 38/53.5 0.711/***<0.0001 0.369/*0.023 4.416 ± 1.701 -0.131/0.4343 6.352 ± 3.954 0.1093/0.5319
Female 33/46.5 0.614/***<0.0001 0.495/**0.003 5.088 ± 1.947 -0.4795/**0.0048 5.861 ± 3.532 0.06432/0.7310
Location Coecum 14/19.7 0.462/0.097 0.396/0.161 4.743 ± 1.781 -0.4492/0.1079 6.564 ± 3.344 0.01322/0.9659
Sigmoideum 30/42.3 0.777/***<0.0001 0.585/**0.001 5.830 ± 7.212 -0.01606/0.9329 6.354 ± 4.606 -0.1492/0.4485
Ascendens 10/14.1 0.879/**0.002 -0.389/0.266 5.010 ± 2.346 -0.1098/0.7617 6.856 ± 3.846 0.2929/0.4422
Flexura hepatica 3/4.2 0.5/1 1/0.333 5.067 ± 1.901 -0.5/>0.9999 4.345 ± 2.270 ND/ND
Lienalis 2/2.8 ND/ND ND/ND 4.450 ± 1.485 ND/ND 4.701 ± 4.101 ND/ND
Transversum 9/12.7 0.711/*0.037 0.819/*0.01 5.167 ± 2.337 -0.7416/*0.0275 4.969 ± 1.492 0.5636/0.1174
Descendens 3/4.2 0.5/1 1/0.333 3.400 ± 0.520 -0.866/0.6667 4.540 ND/ND
Tumor stage T2 13/18.3 0.863/***<0.0001 0.863/***<0.0001 3.500 ± 1.050 -0.37/0.2114 7.635 ± 3.65 0.1553/0.6471
T3 44/62.0 0.652/***<0.0001 0.232/0.129 4.800 ± 1.834 -0.3313/*0.028 5.973 ± 3.611 0.1157/0.4601
T4 14/19.7 0.433/0.122 0.873/***<0.0001 7.671 ± 0.990 -0.3028/0.289 5.416 ± 4.637 -0.5919/*0.0461

*P < 0.05,**P < 0.01, ***P < 0.001 (indicated in bold); ND, not determined (due to low n); statistics of analysed using Spearman’s correlation. #n = 66.